Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-β-D- glucuronide: Effects of dibromosulfophthalein on membrane transport and aglycone formation

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 414-420

  Sabordo, Lucia ^c   Sallustio, Benedetta C ^b   Evans, Allan M ^a   Nation, Roger L ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 O GEMFIBROZIL BETA DEXTRO GLUCURONIDE; ALBUMIN; ANION; DIBROMOSULFOPHTHALEIN; GEMFIBROZIL; GLUCURONIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HYDROLYSIS; DRUG UPTAKE; LIVER PERFUSION; MALE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTILIPEMIC AGENTS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; FEMALE; GEMFIBROZIL; GLUCURONATES; LIVER; MALE; PERFUSION; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SULFOBROMOPHTHALEIN;

EID: 0032987802     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adachi Y, Kinne R, Roy-Chowdhury J, Roy-Chowdhury N, Theilmann L, Tran T and Arias IM (1991) Uptake of bilirubin glucuronides by isolated rat hepatocytes. Gastroenterol Jpn 26:350-355
2. 14C)morphine in the isolated perfused rat liver. Drug Metab Dispos 10:344-349.
3. Bischer A, Iwaki M, Zia-Amirhosseini P and Benet LZ (1995) Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albumin. Drug Metab Dispos 23:900-903.
4. Curtis CG, Danaher TM, Hibbert EA, Morris CL, Scott AM, Woolcott BA and Powell GM (1985) The fate of gemfibrozil and its metabolites in the rat. Biochem Soc Trans 13:1190-1191.
5. De Vries MH, Groothuis GMM, Mulder GJ, Nguyen H and Meijer DKF (1985) Secretion of the organic anion harmol sulfate from liver into blood: Evidence for a carrier-mediated mechanism. Biochem Pharmacol 34:2129-2135.
6. Dhumeaux D, Berthelot P and Javitt NB (1974) Dibromsulphalein (DBSP) estimation of hepatic transport function in man. Eur J Clin Invest 4:181-185.
7. Durham S, Mack R III and Vore M (1985) Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers: Decreased biliary excretion of dibromosulfophthalein in pregnancy. Drug Metab Dispos 13:695-699.
8. Evans AM, O'Brien J and Nation RL (1995) Effect of probenecid and cimetidine on the disposition of morphine and morphine-3-glucuronide in the rat isolated perfused liver. Proc ASCEPT 2:46.
9. Groothuis GMM and Meijer DKF (1996) Drug traffic in the hepatobiliary system. J Hepatol 24:3-28.
10. +/bile acid cotransporter in Xenopus laevis oocytes. J Biol Chem 265:5357-5360.
11. Hargus SJ, Amouzedeh HR, Pumford NR, Myers TG, McCoy SC and Pohl LR (1994) Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem Res Toxicol 7:575-582.
12. Hayball PJ, Nation RL and Bochner F (1992) Stereoselective interactions of ketoprofen glucuronides with human plasma protein and serum albumin. Biochem Pharmacol 44:291-299.
13. Hinchman CA, Truong AT and Ballatori N (1993) Hepatic uptake of intact glutathione S-conjugate, inhibition by organic anions, and sinusoidal catabolism. Am J Physiol 28:G547-G554.
14. Iwakawa S, Spahn H, Benet LZ and Lin ET (1990) Stereoselective binding of the glucuronide conjugates of carprofen enantiomers to human serum albumin. Biochem Pharmacol 39:949-953.
15. --independent organic anion transporter. Proc Natl Acad Sci USA 91:133-137.
16. Jansen PLM, Groothuis GMM, Peters WHM and Meijer DFM (1987) Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary conjugated hyperbilirubinaemia. Hepatology 7:71-76.
17. Javitt NB (1964) Phenol 3,6-dibromphthalein disulfonate, a new compound for the study of liver disease. Prof Soc Exp Biol Med 117:254-257.
18. Jedlitschky G, Leier I, Bohme M, Buchholz U, Bar-Tana J and Keppler D (1994) Hepatobiliary elimination of the peroxisome proliferator nafenopin by conjugation and subsequent ATP-dependent transport across the canalicular membrane. Biochem Pharmacol 48:1113-1120.
19. Keppler D and Arias IM (1997) Hepatic canalicular membrane: Introduction: Transport across the hepatocyte canalicular membrane. FASEB J 11:15-18.
20. Klaassen CD and Plaa GL (1968) Hepatic disposition of phenoldibromphthalein disulfonate and sulfobromophthalein. Am J Physiol 215:971-976.
21. Knauf H, Kolle EU and Mutschler E (1990) Gemfibrozil absorption and elimination in kidney and liver disease. Klin Worchenschr 68:692-698.
22. Kuipers F, Radominska A, Zimniak P, Little JM, Havinga R, Vonk RJ and Lester R (1989) Defective biliary secretion of bile acid 3-O-glucuronides in rats with hereditary conjugated hyperbilirubinaemia. J Lipid Res 30:1835-1845.
23. Meffin PJ, Zilm DM and Veenendaal JR (1983a) A renal mechanism for the clofibric acid-probenecid interaction. J Pharmacol Exp Ther 227:739-742.
24. Meffin PJ, Zilm DM and Veenendaal JR (1983b) Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. J Pharmacol Exp Ther 227:732-738.
25. Meijer DKF, Vonk RJ, Keulemans K and Weitering JG (1977) Hepatic uptake and biliary excretion of dibromosulphthalein: Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of Y and Z protein. J Pharmacol Exp Ther 202:8-21.
26. -) with inherited conjugated hyperbilirubinemia. J Clin Invest 90:2130-2135.
27. Ojingwa JC, Spahn-Langguth H and Benet LZ (1994a) Irreversible binding of tolmetin to macromolecules via its glucuronide: Binding to blood constituents, tissue homogenates and subcellular fractions in vitro. Xenobiotica 24:495-506.
28. Ojingwa JC, Spahn-Langguth H and Benet LZ (1994b) Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma. J Pharmacokinet Biopharm 22:19-39.
29. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK and Groothuis GMM (1995) Hepatobiliary secretion of compounds: Molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215-268.
30. Sallustio BC and Fairchild BA (1995) Biosynthesis, characterisation and direct high-performance liquid chromatographic analysis of gemfibrozil 1-O-β acylglucuronide. J Chromatogr 665:345-353.
31. Sallustio BC, Fairchild BA and Pannall PR (1997a) Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-β-D-glucuronide. Drug Metab Dispos 25:55-60.
32. Sallustio BC, Fairchild BA, Shanahan K, Evans AM and Nation RL (1996) Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver. Drug Metab Dispos 24:984-989.
33. Sallustio BC and Foster DjR (1995) Reactivity of gemfibrozil 1-O-β-acyl glucuronide: Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats. Drug Metab Dispos 23:892-899.
34. Sallustio BC, Harkin LA, Mann MC, Krivickas SJ and Burcham PC (1997b) Genotoxicity of acyl glucuronide metabolites formed from clofibric acid and gemfibrozil: A novel role for phase II-mediated bioactivation in the hepatocarcinogenicity of the parent aglycones. Toxicol Appl Pharmacol 147:459-464.
35. Shimamura H, Suzuki H, Hanano M, Suzuki A, Tagaya O, Horie T and Sugiyama Y (1994) Multiple systems for the biliary excretion of organic anions in rats: Liquiritigenin conjugates as model compounds. J Pharmacol Exp Ther 271:370-378.
36. Spahn-Langguth H and Benet LZ (1992) Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab Rev 24:4-48
37. Takenaka O, Horie T, Suzuki H and Sugiyama Y (1997) Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methyl-amino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: Quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo. J Pharmacol Exp Ther 280:948-958.
38. Vore M (1994) Regulation of drug conjugate processing by hepatocellular transport systems, in Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity (Kauffman FC ed) vol 112, pp 311-338, Springer-Verlag, Berlin.
39. Wilkinson GR and Shand DG (1975) Commentary: A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377-390.
40. Yamazaki M, Tokui T, Ishigami M and Sugiyama Y (1996) Tissue-selective uptake of pravastatin in rats: Contribution of a specific carrier-mediated uptake system. Biopharm Drug Dispos 17:775-789.